Hans Biomed

042520 · KOSDAQ · ₩042520 · 한스바이오메드

₩17,030▼ ₩500 (2.85%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me

Income statement

20252024202320222021
Revenue₩90B₩81B₩78B₩74B₩59B
Cost of sales₩38B₩29B₩33B₩29B₩30B
Gross profit₩52B₩52B₩45B₩46B₩29B
Operating income−₩26B₩626M−₩4.2B₩1.3B−₩20B
Net income−₩32B−₩7.8B−₩24B₩4.9B−₩22B
Net income to shareholders−₩31B−₩7.2B−₩23B₩6.1B−₩18B

Balance sheet

20252024202320222021
Total assets₩126B₩122B₩122B₩132B₩129B
Current assets₩56B₩50B₩50B₩54B₩51B
Cash and equivalents₩8.1B₩7.3B₩6.1B₩7.5B₩7.1B
Total liabilities₩93B₩55B₩72B₩84B₩82B
Current liabilities₩81B₩50B₩65B₩74B₩61B
Borrowings₩41B₩37B₩39B₩54B₩49B
Total equity₩34B₩67B₩50B₩47B₩48B
Shareholders' equity₩34B₩67B₩49B₩46B₩44B

Cash flow

20252024202320222021
Cash from operations₩318M₩1.8B−₩3.7B−₩4.3B−₩15B
Capital spending₩1.7B₩2.6B₩1.9B₩4B₩4.9B
Free cash flow−₩1.4B−₩836M−₩5.7B−₩8.3B−₩20B

Consolidated where available. Amounts in won.

Also known as: Hans Biomed / 한스바이오메드 / 042520 / KRX:042520

Source: KRX statistical information